2018-06-27 |
2018-06-26 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-27 |
2018-06-26 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-27 |
2018-06-26 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
9,103
+0.3%
1.24
11,322
USD
|
9,103
+0.3%
|
1.24
|
11,322
USD
|
|
2018-06-27 |
2018-06-25 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-27 |
2018-06-25 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-27 |
2018-06-25 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
10,672
+0.4%
1.26
13,462
USD
|
10,672
+0.4%
|
1.26
|
13,462
USD
|
|
2018-06-22 |
2018-06-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-22 |
2018-06-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-22 |
2018-06-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
14,520
+0.5%
1.25
18,201
USD
|
14,520
+0.5%
|
1.25
|
18,201
USD
|
|
2018-06-22 |
2018-06-21 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-22 |
2018-06-21 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-22 |
2018-06-21 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
140
+0.0%
1.25
176
USD
|
140
+0.0%
|
1.25
|
176
USD
|
|
2018-06-22 |
2018-06-20 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-22 |
2018-06-20 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-22 |
2018-06-20 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
3,702
+0.1%
1.27
4,685
USD
|
3,702
+0.1%
|
1.27
|
4,685
USD
|
|
2018-06-18 |
2018-06-18 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-18 |
2018-06-18 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-18 |
2018-06-18 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
13,742
+0.5%
1.20
16,532
USD
|
13,742
+0.5%
|
1.20
|
16,532
USD
|
|
2018-06-18 |
2018-06-14 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-18 |
2018-06-14 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-18 |
2018-06-14 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
29,103
+1.0%
1.15
33,521
USD
|
29,103
+1.0%
|
1.15
|
33,521
USD
|
|
2018-06-13 |
2018-06-13 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-13 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-13 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
145,297
+5.1%
1.07
154,741
USD
|
145,297
+5.1%
|
1.07
|
154,741
USD
|
|
2018-06-13 |
2018-06-12 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-12 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-12 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
25,600
+0.9%
1.08
27,630
USD
|
25,600
+0.9%
|
1.08
|
27,630
USD
|
|
2018-06-13 |
2018-06-12 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-12 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-12 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
131,295
+4.9%
1.23
160,902
USD
|
131,295
+4.9%
|
1.23
|
160,902
USD
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
68,705
+2.6%
1.21
82,865
USD
|
68,705
+2.6%
|
1.21
|
82,865
USD
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-06-13 |
2018-06-11 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
300,000
+13.0%
1.18
353,190
USD
|
300,000
+13.0%
|
1.18
|
353,190
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
20,000
+0.9%
1.46
29,100
USD
|
20,000
+0.9%
|
1.46
|
29,100
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
45,000
+2.0%
1.43
64,229
USD
|
45,000
+2.0%
|
1.43
|
64,229
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
0
0.00
0
USD
|
0
|
0.00
|
0
USD
|
|
2018-01-26 |
2018-01-22 |
B
Purchase
|
ARMISTICE CAPITAL, LLC
Large shareholder
|
35,000
+1.6%
1.42
49,697
USD
|
35,000
+1.6%
|
1.42
|
49,697
USD
|
|
2017-11-14 |
2017-11-10 |
B
Purchase
|
MERTON ROBERT C
|
85,700
+878.9%
1.75
149,975
USD
|
85,700
+878.9%
|
1.75
|
149,975
USD
|
|
2017-03-28 |
2017-03-27 |
PS
Planned sale
|
Ramos Anthony Alan
VP, Chief Accounting Officer
|
4,250
-30.5%
2.17
9,240
USD
|
4,250
-30.5%
|
2.17
|
9,240
USD
|
|
2017-03-17 |
2017-03-15 |
PS
Planned sale
|
SMITH LAWRENCE RUSSELL
VP, Vaccine Research
|
875
-4.7%
2.31
2,021
USD
|
875
-4.7%
|
2.31
|
2,021
USD
|
|
2017-02-14 |
2017-02-10 |
PS
Planned sale
|
SMITH LAWRENCE RUSSELL
VP, Vaccine Research
|
4,500
-19.5%
2.26
10,160
USD
|
4,500
-19.5%
|
2.26
|
10,160
USD
|
|
2017-02-03 |
2017-02-01 |
PS
Planned sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
3,750
-4.1%
2.16
8,088
USD
|
3,750
-4.1%
|
2.16
|
8,088
USD
|
|
2017-01-13 |
2017-01-11 |
PS
Planned sale
|
SMITH LAWRENCE RUSSELL
VP, Vaccine Research
|
54
-0.2%
2.48
134
USD
|
54
-0.2%
|
2.48
|
134
USD
|
|
2017-01-12 |
2017-01-10 |
PS
Planned sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
5,763
-5.9%
2.45
14,114
USD
|
5,763
-5.9%
|
2.45
|
14,114
USD
|
|
2016-12-22 |
2016-12-22 |
S
Sale
|
MERTON ROBERT C
Non-Executive Director
|
2,000
-17.0%
2.26
4,520
USD
|
2,000
-17.0%
|
2.26
|
4,520
USD
|
|
2016-12-22 |
2016-12-21 |
S
Sale
|
MERTON ROBERT C
Non-Executive Director
|
2,000
-14.5%
2.22
4,440
USD
|
2,000
-14.5%
|
2.22
|
4,440
USD
|
|
2016-12-20 |
2016-12-20 |
S
Sale
|
MERTON ROBERT C
Non-Executive Director
|
2,000
-12.7%
2.22
4,440
USD
|
2,000
-12.7%
|
2.22
|
4,440
USD
|
|
2016-12-20 |
2016-12-19 |
S
Sale
|
MERTON ROBERT C
Non-Executive Director
|
2,327
-12.9%
2.21
5,143
USD
|
2,327
-12.9%
|
2.21
|
5,143
USD
|
|
2016-12-13 |
2016-12-13 |
S
Sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
4,649
-4.6%
2.40
11,172
USD
|
4,649
-4.6%
|
2.40
|
11,172
USD
|
|
2016-12-13 |
2016-12-12 |
S
Sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
11,050
-9.8%
2.39
26,415
USD
|
11,050
-9.8%
|
2.39
|
26,415
USD
|
|
2016-12-13 |
2016-12-12 |
S
Sale
|
DOUGLAS R GORDON
Non-Executive Director
|
10,078
-48.2%
2.39
24,109
USD
|
10,078
-48.2%
|
2.39
|
24,109
USD
|
|
2016-12-07 |
2016-12-05 |
S
Sale
|
LYONS GARY A
Non-Executive Director
|
7,078
-47.5%
2.30
16,248
USD
|
7,078
-47.5%
|
2.30
|
16,248
USD
|
|
2016-10-12 |
2016-10-11 |
PS
Planned sale
|
SMITH LAWRENCE RUSSELL
VP, Vaccine Research
Officer
|
54
-0.2%
3.05
165
USD
|
54
-0.2%
|
3.05
|
165
USD
|
|
2016-07-13 |
2016-07-11 |
PS
Planned sale
|
SMITH LAWRENCE RUSSELL
VP, Vaccine Research
Officer
|
54
-0.2%
4.46
241
USD
|
54
-0.2%
|
4.46
|
241
USD
|
|
2016-06-14 |
2016-06-14 |
B
Purchase
|
MERTON ROBERT C
Non-Executive Director
|
4,100
+29.3%
4.41
18,067
USD
|
4,100
+29.3%
|
4.41
|
18,067
USD
|
|
2016-06-14 |
2016-06-13 |
B
Purchase
|
MERTON ROBERT C
Non-Executive Director
|
4,900
+54.0%
4.29
21,031
USD
|
4,900
+54.0%
|
4.29
|
21,031
USD
|
|
2016-06-10 |
2016-06-09 |
B
Purchase
|
SAMANT VIJAY B
President & CEO
Executive Director
|
15,700
+16.2%
4.72
74,154
USD
|
15,700
+16.2%
|
4.72
|
74,154
USD
|
|
2016-06-08 |
2016-06-06 |
B
Purchase
|
DOUGLAS R GORDON
Non-Executive Director
|
10,078
+93.1%
4.41
44,444
USD
|
10,078
+93.1%
|
4.41
|
44,444
USD
|
|
2016-06-06 |
2016-06-03 |
B
Purchase
|
LYONS GARY A
Non-Executive Director
|
7,078
+90.4%
4.39
31,089
USD
|
7,078
+90.4%
|
4.39
|
31,089
USD
|
|
2016-03-17 |
2016-03-15 |
PS
Planned sale
|
SMITH LAWRENCE RUSSELL
VP, Vaccine Research
Officer
|
8,750
-3.6%
0.41
3,583
USD
|
8,750
-3.6%
|
0.41
|
3,583
USD
|
|
2016-03-03 |
2016-03-03 |
PS
Planned sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
5,900
-0.6%
0.37
2,199
USD
|
5,900
-0.6%
|
0.37
|
2,199
USD
|
|
2016-03-03 |
2016-03-02 |
PS
Planned sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
14,000
-1.4%
0.37
5,120
USD
|
14,000
-1.4%
|
0.37
|
5,120
USD
|
|
2016-03-03 |
2016-03-01 |
PS
Planned sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
17,600
-1.7%
0.35
6,237
USD
|
17,600
-1.7%
|
0.35
|
6,237
USD
|
|
2016-02-22 |
2016-02-19 |
PS
Planned sale
|
Ramos Anthony Alan
VP, Chief Accounting Officer
Officer
|
7,500
-5.1%
0.33
2,477
USD
|
7,500
-5.1%
|
0.33
|
2,477
USD
|
|
2016-01-26 |
2016-01-25 |
PS
Planned sale
|
Ramos Anthony Alan
VP, Chief Accounting Officer
Officer
|
193
-0.1%
0.35
68
USD
|
193
-0.1%
|
0.35
|
68
USD
|
|
2016-01-13 |
2016-01-12 |
PS
Planned sale
|
SAMANT VIJAY B
President & CEO
Executive Director
|
11,202
-1.1%
0.35
3,904
USD
|
11,202
-1.1%
|
0.35
|
3,904
USD
|
|
2016-01-13 |
2016-01-11 |
PS
Planned sale
|
SMITH LAWRENCE RUSSELL
VP, Vaccine Research
Officer
|
974
-0.4%
0.36
351
USD
|
974
-0.4%
|
0.36
|
351
USD
|
|